Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
March 8, 2014
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India
Ramesh B V Nimmagadda, Raghunadharao Digumarti, Reena Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy
Purvish M Parikh, Ashok Vaid, Suresh H Advani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 3, 2011
A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer
Raghunadharao Digumarti, Yenyun Wang, Ganapathi Raman, et al.
Indian Journal of Cancer
|
March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancer
Kumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 27, 2012
A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline
Anantbhushan A Ranade, Poonamalle P Bapsy, Shona Nag, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 29, 2017
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells
Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu, et al.
JCO Global Oncology
|
November 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)
Anant Ramaswamy, Anand Kulkarni, George John, et al.
Journal of Pediatric Genetics
|
September 10, 2021
Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1
Parag M Tamhankar, Lakshmi Vasudevan, Pratima Kondurkar, et al.
International Journal of Cancer
|
November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India
George Abraham, Vanita Noronha, Senthil Rajappa, et al.
Physics in Medicine and Biology
|
May 21, 2016
Characterizing proton-activated materials to develop PET-mediated proton range verification markers
Jongmin Cho, Geoffrey S Ibbott, Matthew D Kerr, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
March 8, 2014
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India
Ramesh B V Nimmagadda, Raghunadharao Digumarti, Reena Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 5, 2011
Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy
Purvish M Parikh, Ashok Vaid, Suresh H Advani, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 3, 2011
A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer
Raghunadharao Digumarti, Yenyun Wang, Ganapathi Raman, et al.
Indian Journal of Cancer
|
March 28, 2022
CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancer
Kumar Prabhash, Bivas Biswas, Sachin Khurana, et al.
Asia-Pacific Journal of Clinical Oncology
|
November 27, 2012
A multicenter phase II randomized study of Cremophor-free polymeric nanoparticle formulation of paclitaxel in women with locally advanced and/or metastatic breast cancer after failure of anthracycline
Anantbhushan A Ranade, Poonamalle P Bapsy, Shona Nag, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
March 29, 2017
HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells
Krisha Desai, Radhika Aiyappa, Jyothi S Prabhu, et al.
JCO Global Oncology
|
November 30, 2023
Survival of Trial-Like and Non-Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP)
Anant Ramaswamy, Anand Kulkarni, George John, et al.
Journal of Pediatric Genetics
|
September 10, 2021
Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1
Parag M Tamhankar, Lakshmi Vasudevan, Pratima Kondurkar, et al.
International Journal of Cancer
|
November 9, 2021
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India
George Abraham, Vanita Noronha, Senthil Rajappa, et al.
Physics in Medicine and Biology
|
May 21, 2016
Characterizing proton-activated materials to develop PET-mediated proton range verification markers
Jongmin Cho, Geoffrey S Ibbott, Matthew D Kerr, et al.
Page
of 5